In agreement with its effects on acute myeloid leukemia (AML) and other solid tumor types, apatinib triggered the mitochondrial pathway of apoptosis in T-ALL cells partially by tilting the equilibrium of the BCL2 family proteins toward the proapoptotic members. This evidence concerns the gene BCL2 and acute myeloid leukemia.